Trofinetide for the Treatment of Rett Syndrome: Results From the Open-Label LILAC Study

被引：0
|
作者：
Percy, A.
Neul, J.
Benke, T.
Berry-Kravis, E.
Glaze, D.
Marsh, E.
An, D.
Bishop, K.
Youakim, J.
机构：
来源：
ANNALS OF NEUROLOGY | 2023年 / 94卷
关键词：
Neurodevelopmental Disorders;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
178
引用
收藏
页码：S94 / S95
页数：2
相关论文
共 50 条
  • [41] Venlafaxine in the treatment of dysthymia: An open-label study
    Hellerstein, DJ
    Batchelder, ST
    Little, SAS
    Fedak, MJ
    Kreditor, D
    Rosenthal, J
    JOURNAL OF CLINICAL PSYCHIATRY, 1999, 60 (12) : 845 - 849
  • [42] An open-label study of amisulpride in the treatment of mania
    Vieta, E
    Ros, S
    Goikolea, JM
    Benabarre, A
    Popova, E
    Comes, M
    Capapey, J
    Sánchez-Moreno, J
    JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (05) : 575 - 578
  • [43] Treatment of tinnitus with cyclobenzaprine: an open-label study
    Vanneste, Sven
    Figueiredo, Ricardo
    De Ridder, Dirk
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2012, 50 (05) : 338 - 344
  • [44] Profile of Trofinetide in the Treatment of Rett Syndrome: Design, Development and Potential Place in Therapy
    Camillo, Laura
    Pozzi, Marco
    Bernardo, Pia
    Pisano, Simone
    Nobile, Maria
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2024, 18 : 5023 - 5040
  • [45] Oral sildenafil treatment for Eisenmenger syndrome: a prospective, open-label, multicentre study
    Zhang, Zhen-Ning
    Jiang, Xin
    Zhang, Rui
    Li, Xin-Li
    Wu, Bing-Xiang
    Zhao, Qin-Hua
    Wang, Yong
    Dai, Li-Zhi
    Pan, Lei
    Gomberg-Maitland, Mardi
    Jing, Zhi-Cheng
    HEART, 2011, 97 (22) : 1876 - 1881
  • [46] Trofinetide Treatment Demonstrates a Benefit Over Placebo for the Ability to Communicate in Rett Syndrome
    Neul, Jeffrey L.
    Percy, Alan K.
    Benke, Timothy A.
    Berry-Kravis, Elizabeth M.
    Glaze, Daniel G.
    Peters, Sarika U.
    Marsh, Eric D.
    An, Di
    Bishop, Kathie M.
    Youakim, James M.
    PEDIATRIC NEUROLOGY, 2024, 152 : 63 - 72
  • [47] Consolidated results from the open-label extension study of ecallantide for the treatment of acute attacks of hereditary angioedema
    Riedl, M.
    MacGinnitie, A.
    Stolz, L.
    ALLERGY, 2011, 66 : 109 - 109
  • [48] Treatment of Upper Facial Lines With DaxibotulinumtoxinA for Injection: Results From an Open-Label Phase 2 Study
    Dover, Jeffrey S.
    Humphrey, Shannon D.
    Lorenc, Z. Paul
    Shamban, Ava
    Gross, Todd M.
    Rubio, Roman G.
    Vitarella, Domenico
    DERMATOLOGIC SURGERY, 2023, 49 (01) : 60 - 65
  • [49] Long-Term Results from an Open-Label Extension Study of Atacicept for the Treatment of IgA Nephropathy
    Barratt, Jonathan
    Barbour, Sean
    Brenner, Robert
    Cooper, Kerry
    Wei, Xuelian
    Eren, Necmi
    Floege, Juergen
    Jha, Vivekanand
    Kim, Sung Gyun
    Maes, Bart
    Phoon, Richard K. S.
    Singh, Harmeet
    Tesar, Vladimir
    Lafayette, Richard
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024,
  • [50] Design and outcome measures of LAVENDER, a phase 3 study of trofinetide for Rett syndrome
    Neul, Jeffrey L.
    Percy, Alan K.
    Benke, Timothy A.
    Berry-Kravis, Elizabeth M.
    Glaze, Daniel G.
    Peters, Sarika U.
    Jones, Nancy E.
    Youakim, James M.
    CONTEMPORARY CLINICAL TRIALS, 2022, 114
12345